Prometheus Biosciences, Inc. (16)

Browse by Contract Category

Contracts

Amended and Restated Investors Rights Agreement, dated October 30, 2020, by and among the Registrant and certain of its stockholders (Filed With SEC on February 19, 2021)
Prometheus Biosciences, Inc. 2017 Equity Incentive Plan, as amended, including form of stock option agreement thereunder (Filed With SEC on February 19, 2021)
Form of Indemnification Agreement for Directors and Officers (Filed With SEC on February 19, 2021)
Sublease Agreement, dated December 31, 2020, by and between Prometheus Laboratories Inc. and the Registrant (Filed With SEC on February 19, 2021)
Exclusive License Agreement, dated September 1, 2017, by and between Cedars-Sinai Medical Center and the Registrant, as amended (Filed With SEC on February 19, 2021)
Co-development and Manufacturing Agreement, dated as of July 30, 2020, by and between Dr. Falk Pharma GmbH and the Registrant (Filed With SEC on February 19, 2021)
Warrant issued to Oxford Finance LLC, dated January 24, 2020 (Filed With SEC on February 19, 2021)
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Mark C. McKenna and the Registrant (Filed With SEC on February 19, 2021)
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Keith W. Marshall, Ph.D. and the Registrant (Filed With SEC on February 19, 2021)
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Allison Luo, M.D. and the Registrant (Filed With SEC on February 19, 2021)
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Timothy K. Andrews and the Registrant (Filed With SEC on February 19, 2021)
Loan and Security Agreement, dated January 24, 2020, by and among Oxford Finance LLC, Prometheus Laboratories, Inc. and the Registrant, as amended (Filed With SEC on February 19, 2021)
Exclusive License Agreement, dated March 22, 2019, by and between Cedars-Sinai Medical Center and the Registrant (Filed With SEC on February 19, 2021)
Exclusive License Agreement, dated March 22, 2019, by and between Cedars-Sinai Medical Center and the Registrant (Filed With SEC on February 19, 2021)
Companion Diagnostics Development and Collaboration Agreement, dated as of March 25, 2019, by and between Millennium Pharmaceuticals, Inc. and the Registrant (Filed With SEC on February 19, 2021)
License Agreement, dated March 18, 2020, by and between Alloy Therapeutics, LLC and the Registrant (Filed With SEC on February 19, 2021)